Bristol-Myers Squibb Company's Head of Corporate and Business Development, Tamar D. Howson, to Address the Pharmaceutical Strategic Alliances Conference on Sept. 27 in New York
Posted on: Monday, 19 September 2005, 15:01 CDT
Bristol-Myers Squibb Company's (NYSE:BMY) senior vice president, corporate and business development, will address the 2005 Pharmaceutical Strategic Alliances Conference, organizer Windhover Information, Inc. announced today.
Tamar D. Howson will join other industry leaders in a panel discussion on Sept. 27 at 2:30 p.m. to discuss co-promotion agreements and other partnerships between large, small and mid-sized companies.
Bristol-Myers Squibb has built five $1-billion-plus franchises with corporate partners in the past decade alone. The company currently has more than 170 collaborations with about 130 companies and research institutions around the world.
Such partnerships, in combination with internal research and development, play an important role in Bristol-Myers Squibb's strategy of serving specialists and high-value primary care physicians by focusing its product portfolio and pipeline on disease areas of significant unmet need, where innovative medicines can help patients with serious illnesses.
Before joining Bristol-Myers Squibb in 2001, Howson was an independent business consultant helping several biotechnology companies in the development of strategic and tactical partnering plans. From 1991 to 2000, Howson was senior vice president and director, Business Development, for SmithKline Beecham Corporation. She holds a B.Sc. in Chemical Engineering from Technion (Haifa, Israel), an M.S. in Chemical Engineering from City College of New York, and an M.B.A. in Finance, International Business and Marketing from Columbia University.
Registration information on the Pharmaceutical Strategic Alliances Conference, Sept. 25 through Sept. 27 in New York, is available at www.windhover.com/psa.
Source: Business Wire
Related Articles
- Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company
- Bristol-Myers Squibb Furthers Strategic IT Relationship With IBM
- The Future is Bright for Envision Solar, LLC, As the Solar Developer Announces a Series of Strategic Alliances Worldwide
- GT Software Names George Reiner As Director of Business Development; Industry Veteran to Bolster Company's Partnership Program
- U.S. Developments Enhance Bavarian Nordic's Strategic Position
- Recent Research on Leukemia Has Revealed 85 Drug Candidates in Phase II or III Stage of Development and More Than 50 Companies Are Involved In the Development of These Drugs
- Digital Fountain Names Vice President of Business Development; Jim Bennette Brings Strategic Leadership to Further Establish Digital Fountain in Networked Entertainment Applications
- Petrol Oil and Gas Develops New Natural Gas Resources; Company's ReSource America Initiative to Help Move America Toward Energy Independence; Please Note Tuesday, April 25 Event
- Nu Horizons Electronics Corp. Named Fastest Growing Channel Development Partner By Sun Microsystems; Company Awarded for Outstanding Revenue and Design Win Growth
- PacificNet Selected By Guangzhou Metro to Develop E-Business and CRM Platform; Company Wins Highly Competitive Public Project Tender
 |
 |
User Comments (0)
RSS Feeds